Vertraagde tijd
Bombay S.E.
07:12:48 02-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
8.534
INR
|
+2,52%
|
|
+4,80%
|
+5,79%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Marktkapitalisatie
1 |
146.307
|
161.572
|
191.565
|
181.781
|
134.721
|
191.709
|
191.709
|
-
|
Bedrijfswaarde
1 |
146.307
|
161.572
|
191.565
|
181.781
|
134.721
|
185.790
|
191.709
|
191.709
|
K/w-verhouding
|
38,4
x
|
39
x
|
40,1
x
|
19,2
x
|
21,7
x
|
30,8
x
|
29,9
x
|
26,5
x
|
Dividendrendement
|
1,32%
|
1,51%
|
4,39%
|
6,21%
|
9,74%
|
4,17%
|
2,16%
|
2,38%
|
Marktkapitalisatie/omzet
|
5,28
x
|
5,26
x
|
6,6
x
|
6,15
x
|
4,86
x
|
6,52
x
|
6,2
x
|
5,64
x
|
Bedrijfswaarde/omzet
|
5,28
x
|
5,26
x
|
6,6
x
|
6,15
x
|
4,86
x
|
6,52
x
|
6,2
x
|
5,64
x
|
Bedrijfswaarde/EBITDA
|
23,5
x
|
24,3
x
|
26,9
x
|
23,8
x
|
19,1
x
|
23,1
x
|
21,7
x
|
19,4
x
|
Bedrijfswaarde/FCF
|
46,5
x
|
48
x
|
33,6
x
|
33,9
x
|
35,8
x
|
94,5
x
|
24,3
x
|
24,4
x
|
FCF Yield
|
2,15%
|
2,08%
|
2,97%
|
2,95%
|
2,79%
|
1,06%
|
4,12%
|
4,1%
|
Price to Book
|
6,58
x
|
6,61
x
|
9,03
x
|
8,16
x
|
10,5
x
|
18,3
x
|
15,2
x
|
12,6
x
|
Aantal aandelen (in duizenden)
|
23.031
|
23.031
|
23.031
|
23.031
|
23.031
|
23.031
|
23.031
|
-
|
Referentieprijs
2 |
6.353
|
7.016
|
8.318
|
7.893
|
5.850
|
8.324
|
8.324
|
8.324
|
Datum van publicatie
|
26-02-19
|
25-02-20
|
23-02-21
|
23-02-22
|
23-02-23
|
23-02-24
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Omzet
1 |
27.708
|
30.706
|
29.019
|
29.566
|
27.701
|
28.511
|
30.945
|
33.986
|
EBITDA
1 |
6.235
|
6.653
|
7.131
|
7.625
|
7.044
|
8.040
|
8.855
|
9.883
|
Bedrijfsresultaat (EBIT)
1 |
5.208
|
5.654
|
6.309
|
6.958
|
6.625
|
7.644
|
8.456
|
9.484
|
Operationele Marge
|
18,8%
|
18,41%
|
21,74%
|
23,53%
|
23,92%
|
26,81%
|
27,33%
|
27,9%
|
Resultaat voor belastingen (EBT)
1 |
6.098
|
5.999
|
6.772
|
12.576
|
8.643
|
8.458
|
9.008
|
10.145
|
Nettowinst (verlies)
1 |
3.806
|
4.142
|
4.776
|
9.444
|
6.206
|
6.032
|
6.410
|
7.231
|
Nettomarge
|
13,74%
|
13,49%
|
16,46%
|
31,94%
|
22,4%
|
21,16%
|
20,72%
|
21,28%
|
WPA
2 |
165,5
|
179,8
|
207,4
|
410,1
|
269,5
|
261,9
|
278,4
|
314,1
|
Free Cash Flow
1 |
3.147
|
3.365
|
5.697
|
5.358
|
3.765
|
1.965
|
7.904
|
7.856
|
FCF-marge
|
11,36%
|
10,96%
|
19,63%
|
18,12%
|
13,59%
|
6,89%
|
25,54%
|
23,12%
|
Kasstroomconversie (ebitda)
|
50,47%
|
50,58%
|
79,89%
|
70,27%
|
53,45%
|
24,44%
|
89,27%
|
79,49%
|
Kasstroomconversie (nettowinst)
|
82,69%
|
81,24%
|
119,28%
|
56,73%
|
60,67%
|
32,58%
|
123,3%
|
108,65%
|
Dividend per aandeel
2 |
84,00
|
106,0
|
365,0
|
490,0
|
570,0
|
347,0
|
179,9
|
198,1
|
Datum van publicatie
|
26-02-19
|
25-02-20
|
23-02-21
|
23-02-22
|
23-02-23
|
23-02-24
|
-
|
-
|
Fiscaal tijdperk: december |
2020 Q3
|
2020 Q4
|
2021 Q1
|
2021 Q2
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Omzet
1 |
6.866
|
7.203
|
7.251
|
7.891
|
7.545
|
6.879
|
7.070
|
6.993
|
6.919
|
6.719
|
7.365
|
7.263
|
7.006
|
7.111
|
7.730
|
EBITDA
1 |
1.922
|
1.670
|
1.894
|
2.471
|
1.988
|
1.272
|
1.945
|
1.611
|
1.819
|
1.669
|
2.299
|
2.141
|
1.924
|
2.022
|
2.396
|
Bedrijfsresultaat (EBIT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operationele Marge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Resultaat voor belastingen (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
|
-
|
1.230
|
-
|
1.783
|
5.298
|
904
|
2.384
|
1.204
|
1.824
|
1.309
|
-
|
1.783
|
1.536
|
1.620
|
1.767
|
Nettomarge
|
-
|
17,08%
|
-
|
22,6%
|
70,22%
|
13,14%
|
33,72%
|
17,22%
|
26,36%
|
19,48%
|
-
|
24,55%
|
21,92%
|
22,78%
|
22,86%
|
WPA
|
-
|
-
|
-
|
77,42
|
-
|
-
|
-
|
-
|
56,84
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
27-10-20
|
23-02-21
|
27-04-21
|
27-07-21
|
26-10-21
|
23-02-22
|
26-04-22
|
26-07-22
|
03-11-22
|
23-02-23
|
10-05-23
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
3.147
|
3.365
|
5.697
|
5.358
|
3.765
|
1.965
|
7.904
|
7.856
|
ROE (netto-inkomsten/eigen vermogen)
|
17,9%
|
17,8%
|
20,9%
|
26,6%
|
30%
|
51,5%
|
54,9%
|
51,1%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
2 |
965,0
|
1.062
|
921,0
|
968,0
|
555,0
|
442,0
|
546,0
|
662,0
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
592
|
758
|
414
|
230
|
222
|
343
|
744
|
627
|
Capex/omzet
|
2,14%
|
2,47%
|
1,43%
|
0,78%
|
0,8%
|
1,2%
|
2,4%
|
1,84%
|
Datum van publicatie
|
26-02-19
|
25-02-20
|
23-02-21
|
23-02-22
|
23-02-23
|
23-02-24
|
-
|
-
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +5,79% | 2,3 mld. | | +20,62% | 43,18 mld. | | +20,10% | 22,59 mld. | | +15,11% | 14,56 mld. | | +42,11% | 11,5 mld. | | -8,80% | 6,93 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +10,21% | 5,36 mld. | | -2,27% | 4,81 mld. |
Generieke geneesmiddelen
|